Skip to content

Acupuncture combined with jianpibushenhuoxuefang (modified Yulin Decoction) Clinical study on treatment of premature ovarian failure of spleen kidney yang deficiency syndrome

Acupuncture combined with jianpibushenhuoxuefang (modified Yulin Decoction) Clinical study on treatment of premature ovarian failure of spleen kidney yang deficiency syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16010116
Enrollment
Unknown
Registered
2016-12-08
Start date
2016-11-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Failure

Interventions

control group:Invigorating spleen and kidney and activating blood circulation
experimental group:Acupuncture combined with Invigorating the spleen and kidney and promoting blood circulation

Sponsors

Beijing Chinese Medicine Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Aged 18 to 40 years old; in accordance with POF diagnostic criteria of Western medicine and traditional Chinese medicine spleen deficiency syndrome diagnosis standard; 4 weeks did not participate in other clinical trials; in February did not take the disease associated with Chinese and Western medicine.

Exclusion criteria

Exclusion criteria: Congenital abnormal development of reproductive organs, reproductive organs acquired organic diseases and damage caused by primary or secondary amenorrhea due to thyroid dysfunction; amenorrhea; multi drug allergy or known allergy to the drug composition; the combination of heart liver and kidney and hematopoietic system disease, severe mental illness may have pregnancy; the patients did not meet the inclusion criteria; and no prescribed medication, can not determine the efficacy or incomplete data curative effect judge.

Design outcomes

Primary

MeasureTime frame
Follicle-Stimulating Hormone;Luteinizing Hormone;estradiol;

Secondary

MeasureTime frame
TCM score;uterine size;endometrial thickness;ovarian size;blood routine examination;urine routine test;stool routine test;liver function;renal function;electrocardiogram;basal body temperature;

Countries

China

Contacts

Public ContactXiuXiangteng

Affiliated Beijing Chinese Medicine Hospital of Capital Medical University

tengxx@126.com+86 13717987052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026